UNSPSC 85813113: Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J829

UNSPSC 85813113 Introduction of other anti-infective into biliary and pancreatic tract via natural or artificial opening endoscopic, a Commodity code, does not align with the work state and local governments are actually buying under recent solicitations in this dataset. The code describes a specific medical procedure — therapeutic injection of anti-infective agents into biliary or pancreatic systems via endoscopy — yet the recent opportunities tagged to this code span telehealth services, occupational health evaluations, cancer registry operations, medical director oversight, emergency medical services staffing, and opioid use disorder treatment and recovery. These procurement activities represent clinical administration, health system staffing, public health programming, and behavioral health service delivery — categories fundamentally distinct from endoscopic therapeutic intervention.

The recent solicitations show no procurement activity matching the code's nominal scope. Inland Empire Health Plan requested virtual urgent care services; San Mateo Medical Center solicited cancer registry and retinal screening device services; Nevada Health Authority issued RFPs for PACE operations and rural value-based care facilitation; and multiple state and county health departments sought employee wellness, EMS staffing, occupational health screening, and opioid abatement programs. The geographic spread spans California, Georgia, Nevada, Colorado, Florida, and numerous other jurisdictions, but none of the representative recent opportunities reflects endoscopic anti-infective administration. This code appears to carry a taxonomy mislabeling or is receiving erroneous opportunity tagging at the state and local level; business development professionals should treat this code as inactive for procurement purposes and verify correct UNSPSC alignment with issuers before pursuing opportunities listed under it.